“…Resistance to multisite inhibitors, DMIs, anilinopyrimidines and SDHIs are still monitored with biological tests. For benzimidazoles and QoIs, resistance was found to be determined by single mutation within the target genes (β-tubulin and cytochrome b, respectively) (Quello et al, 2010;Fontaine et al, 2008). These mutations were detected after partial PCR amplification of these genes and digestion of the PCR product by a restriction enzyme that recognizes the restriction site generated (or lost) by the mutation determining resistance (PCR-RFLP or CAPS test).…”